Alpha-1 antitrypsin deficiency links a genetic result to two different biological problems: insufficient protective protein reaching the lungs and, with certain variants, abnormal protein accumulating inside liver cells. A result such as Pi*MZ or Pi*ZZ needs to be read alongside the blood protein level, the test method, symptoms and exposures. The label alone does not tell you how much organ damage is present.
One protein, two mechanisms
SERPINA1 provides the instructions for alpha-1 antitrypsin, usually abbreviated AAT. The liver produces the protein and releases it into the circulation; one of its jobs is to restrain neutrophil elastase in the lungs. Too little effective AAT leaves lung tissue more vulnerable to injury. Some abnormal proteins, especially the Z form, can form polymers that are retained in liver cells and contribute to liver injury. These are related but distinct mechanisms. MedlinePlus Genetics: SERPINA1.
Not all low-AAT genotypes have the same liver mechanism. Null alleles may produce no protein, giving substantial lung risk without the same polymer accumulation. A low concentration therefore should not be translated into a uniform liver prognosis.
What do M, S and Z mean?
They are established names for common AAT protein variants or corresponding alleles. M usually describes a normal form; S and Z are associated with reduced circulating levels. The two letters describe the pair inherited from the parents. Rare variants also exist, so a test restricted to S and Z is not a complete inventory of SERPINA1 variation. MedlinePlus condition overview.
| Example | Useful interpretation | A conclusion to avoid |
|---|---|---|
| MZ | One M and one Z allele; assess exposures and clinical findings | “Carrier” means either no risk or inevitable disease |
| ZZ | Often severe deficiency, with important lung and liver risks | Every person will develop the same complications |
| SZ | A variable biochemical and clinical picture | All SZ results are equivalent to ZZ |
| Discordant or rare result | Reconcile concentration, genotype and protein phenotype | A limited negative panel excludes every relevant allele |
GeneReviews describes how genotype, concentration and exposures shape risk. Smoking is particularly important for lung outcomes; knowing the genotype does not replace evaluating symptoms or lung function. GeneReviews: alpha-1 antitrypsin deficiency.
Does an MZ result matter for the liver?
It can. A large population study associated heterozygosity for the Z allele with increased liver-disease risk and found that higher body mass index amplified some associations with liver-injury markers. This is evidence about groups, not a forecast that an individual with MZ will develop cirrhosis. It supports assessing other liver risks rather than dismissing MZ as always harmless or treating it as equivalent to ZZ. Hakim and colleagues: Z-allele heterozygosity and liver disease.
Read the laboratory results together
AAT is an acute-phase protein: inflammation can increase its concentration. Protein concentration ranges also overlap between genotypes. A result within the local reference range, particularly during illness, cannot by itself settle an inherited-risk question. The ERS statement describes combining concentration with protein phenotyping or genetic testing, and considering additional analysis when the results disagree. European Respiratory Society statement.
The 2016 adult clinical guideline recommends genotyping at least S and Z when testing symptomatic people, with appropriate confirmatory methods. It specifically cautions against AAT-level testing alone for family testing. Test selection should follow the clinical and family question, rather than relying on the cheapest single number. Alpha-1 Foundation clinical practice guideline.
Two practical examples
Fictional example: MZ and raised liver enzymes. Amir is told he is “only a carrier,” but his liver tests remain abnormal. His clinician evaluates metabolic risk, alcohol exposure, medications and other liver conditions, with fibrosis assessment when indicated. The MZ finding belongs in that assessment; it neither proves the cause of every abnormality nor makes the abnormal results irrelevant.
Fictional example: a reassuring level during infection. Helen’s sibling has a documented ZZ result. Her AAT concentration was measured while she had a chest infection and fell inside the laboratory’s reference interval. The clinician checks the family report and arranges genotype-informed assessment rather than declaring the inherited question answered by that concentration alone.
Can alpha-1 antitrypsin deficiency be passed down?
Yes. Inheritance is commonly described as autosomal codominant because both alleles contribute to the protein pattern. For a mother with MZ and a father with MZ, each pregnancy has a 25% chance of MM, 50% of MZ and 25% of ZZ. These are genotype probabilities, not the probabilities of developing emphysema or liver disease. They restart with each pregnancy and assume those parental genotypes have been established. Inheritance overview.
Questions worth taking to the appointment
- Were the results a protein concentration, protein phenotype, limited genotype panel or sequencing?
- Was the sample taken during inflammation, and do the different results agree?
- Which lung and liver assessments are relevant to my symptoms and genotype?
- Which exposures can I reduce, and what follow-up has actually been agreed?
- Which relatives could benefit from counselling and testing?
Learn how relative risks differ from personal probabilities and how family testing works. Use the research comparison worksheet to record a study’s population, genotype definitions and outcomes before applying a headline to your own result.